-
Notice: Release of Draft Guidance Document for Consultation: Comparative...
The purpose of this document is to provide sponsors of new drug submissions and abbreviated new drug submissions with the information necessary to comply with Sections... -
Consumer Product Enforcement Summary Report: Consumer Chemicals and...
The purpose of this Cyclical Enforcement (CE) project was to verify compliance of five categories of consumer chemicals which are subject to the Consumer Chemicals and... -
Summary Safety Review - Gabapentin - Assessing the Potential Risk of Serious...
In 2014, the product information for gabapentin products was updated to warn about the risk of serious breathing problems (respiratory depression) when it is used with an... -
Notice: Medical Device Cybersecurity
In recent years, there has been a dramatic increase in the level of interconnectedness and data exchange between medical devices and their network environments. Increased... -
Canada's Access to Medicines Regime background
In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related... -
Canada's Access to Medicines Regime documents
This section contains additional information and documentation. -
Hazardous Substance Assessment - Diethylene Glycol Monomethyl Ether
Hazardous Substance Assessments are prepared by Health Canada as educational and information resources. -
Proposed Registration Decision PRD2022-18, Ipflufenoquin and Kinoprol 20 SC
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2022-18, Ipflufenoquin and Kinoprol 20 SC provides... -
Compulsory licences under Canada's Access to Medicines Regime
Governments can override patent rights when necessary. In such instances, the government authorizes a third party to use the patented invention without the patent holder's... -
Proposed Guidance technical document for waterborne pathogens
A basic understanding of the different types of waterborne pathogens—their sources, the measures that are important for their control and the people that are most at risk for... -
Review of your Application
All Clinical Trial Applications (CTAs) and Clinical Trial Application Amendments (CTA-As) are subject to a 30-day default review period from the date of receipt of a complete... -
Yukon virtual care action plan
Health Yukon consists of a number of initiatives that leverage technology to increase access to care, provide opportunities to bring care closer to home, improve delivery and... -
Registration and Disclosure of Clinical Trial Information
Health Canada's approach to the registration and disclosure of Canadian clinical trial information -
Nutrient Value of Some Common Foods
For this reason we have produced this booklet entitled Nutrient Value of Some Common Foods. This publication lists the nutrients most relevant in terms of public health and... -
List of Medical Devices - Notification of Shortages
List of specified medical devices related to COVID-19. -
Radon Gas is in Your Home
Radon is the #1 cause of lung cancer in non-smokers. Test to find out if you have an unsafe level -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
Available data on formaldehyde concentrations in drinking water indicate that intake of formaldehyde from this source is well below the level at which adverse health effects may... -
A Prescription for Canada: Achieving Pharmacare for All
Final Report of the Advisory Council on the Implementation of National Pharmacare